Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
Eur J Endocrinol. 2022 Oct 26;187(6):777-786. doi: 10.1530/EJE-22-0368. Print 2022 Dec 1.
Differentiation between central diabetes insipidus (cDI) and primary polydipsia (PP) remains challenging in clinical practice. Although the hypertonic saline infusion test led to high diagnostic accuracy, it is a laborious test requiring close monitoring of plasma sodium levels. As such, we leverage machine learning (ML) to facilitate differential diagnosis of cDI.
We analyzed data of 59 patients with cDI and 81 patients with PP from a prospective multicenter study evaluating the hypertonic saline test as new test approach to diagnose cDI. Our primary outcome was the diagnostic accuracy of the ML-based algorithm in differentiating cDI from PP patients.
The data set used included 56 clinical, biochemical, and radiological covariates. We identified a set of five covariates which were crucial for differentiating cDI from PP patients utilizing standard ML methods. We developed ML-based algorithms on the data and validated them with an unseen test data set.
Urine osmolality, plasma sodium and glucose, known transsphenoidal surgery, or anterior pituitary deficiencies were selected as input parameters for the basic ML-based algorithm. Testing it on an unseen test data set resulted in a high area under the curve (AUC) score of 0.87. A further improvement of the ML-based algorithm was reached with the addition of MRI characteristics and the results of the hypertonic saline infusion test (AUC: 0.93 and 0.98, respectively).
The developed ML-based algorithm facilitated differentiation between cDI and PP patients with high accuracy even if only clinical information and laboratory data were available, thereby possibly avoiding cumbersome clinical tests in the future.
在临床实践中,区分中枢性尿崩症(cDI)和原发性多尿仍然具有挑战性。尽管高渗盐水输注试验具有较高的诊断准确性,但它是一项费力的试验,需要密切监测血浆钠水平。因此,我们利用机器学习(ML)来促进 cDI 的鉴别诊断。
我们分析了来自一项前瞻性多中心研究的数据,该研究评估了高渗盐水试验作为诊断 cDI 的新试验方法,该研究纳入了 59 例 cDI 患者和 81 例 PP 患者。我们的主要结局是基于 ML 的算法区分 cDI 和 PP 患者的诊断准确性。
数据集包括 56 项临床、生化和影像学协变量。我们利用标准 ML 方法确定了一组五个关键协变量,用于区分 cDI 和 PP 患者。我们在数据上开发了基于 ML 的算法,并使用未见过的测试数据集进行了验证。
尿渗透压、血浆钠和葡萄糖、已知的经蝶窦手术或前垂体功能减退被选为基本基于 ML 的算法的输入参数。在未见过的测试数据集上进行测试,得到了较高的曲线下面积(AUC)评分 0.87。通过添加 MRI 特征和高渗盐水输注试验的结果,进一步提高了基于 ML 的算法的性能(AUC:0.93 和 0.98)。
即使只有临床信息和实验室数据可用,开发的基于 ML 的算法也能以较高的准确性区分 cDI 和 PP 患者,从而可能在未来避免繁琐的临床检查。